Account statements as of March 31, 2020 are available via the Client access link at the top of this page using your login and password. We have provided our investor letter from Charles Buck, President and CEO, and the preliminary performance information for Q1-2020.
Due to the COVID-19 (coronavirus) outbreak, and to protect our staff, their families and the public, United Church Funds’ New York City offices are closed until further notice. During this time, all operations including Client Services continue as normal, and email and phones will be monitored by staff, working remotely, during regular business hours (9:00 a.m. – 4:30 p.m., EDT)
Today, 23.9% of voting shareholders of AbbVie, a U.S. pharmaceutical company, supported a United Church Funds-led shareholder resolution to report on the “feasibility of incorporating public concern over high drug price into the senior executive compensation arrangement.”
United Church Funds is proud to have coordinated a shareholder resolution with Gilead Sciences, Inc. that received 43.4% support at Gilead’s annual general meeting on May 6, 2020. The resolution requested the company to separate the position of the Chair of the Board from the CEO position.
United Church Funds talked with Rev. John H. Pomeroy, Co-Pastor at First Congregational Church of Pasadena, to learn about the church’s history, mission, and how they deepen their impact in the community through socially responsible investing.
Matt Wagner, Director, Institutional Relationships, discussed with David Klassen, Chief Investment Strategist, the impact of COVID-19 on the global market, what recovery looks like and the benefits of diversification.